ImmunityBio, Inc. (26CA)
Market Closed
23 Feb, 20:00
XFRA 
€
8. 31
+1
+13.61%
€
- Market Cap
- P/E Ratio
- Div Yield
18,158 Volume
-0.93 Eps
€ 7.32
Previous Close Day Range
7.3 9.19
Year Range
1.63 9.19
Want to track 26CA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
26CA earnings report is expected in 6 days (2 Mar 2026)
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
 | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
26CA Earnings Reports FAQ
What is the earnings per share (EPS) for 26CA?
The current EPS is -0.93.
What is the company's earnings growth rate?
ImmunityBio, Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
The next earnings release is expected to be on 2026-03-02, based on the 26CA's typical earnings announcement schedule.
What were the most recent quarterly earnings?
The most recent quarterly earnings for ImmunityBio, Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for 26CA at this time, as ImmunityBio, Inc has no recent EPS data to calculate it.
